GC
OGN icon

Globeflex Capital’s Organon & Co OGN Stock Holding History

Globeflex Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,148
Closed -$151K – 438
2025
Q3 		$151K Sell
14,148
-132,849
-90% -$1.3M 0.02% 332
2025
Q2 		$1.42M Sell
146,997
-500,803
-77% -$5.17M 0.12% 149
2025
Q1 		$9.65M Hold
647,800
– – 0.89% 26
2024
Q4 		$9.67M Hold
647,800
– – 0.82% 27
2024
Q3 		$12.4M Sell
647,800
-5,400
-0.8% -$112K 1.19% 19
2024
Q2 		$13.5M Buy
+653,200
New +$13M 1.41% 14

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

Globeflex Capital's OGN Position: Q4 2025 in Review

Globeflex Capital sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 14,148 shares — an estimated $151K sold.

Globeflex Capital first reported a position in OGN in Q2 2024 and held it in 6 quarters. The position peaked at $13.5M in Q2 2024. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Globeflex Capital reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Globeflex Capital sold 14,148 Organon & Co shares in Q4 2025, an estimated $151K.
  • Globeflex Capital first reported a position in Organon & Co in Q2 2024 and held it in 6 quarters.
  • Globeflex Capital's Organon & Co position peaked at $13.5M in Q2 2024.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Globeflex Capital's 13F filing for Q4 2025, filed 11 Feb 2026.